An update on the interventions and strategies in preventing myopia progression
Madeline KM Kwok 郭家雯, Jason CS Yam 任卓昇, See-mei Lee 李詩眉, Alvin L Young 楊樂旼
HK Pract 2013;35:91-96
Summary
Myopia is a prevalent eye disease in Hong Kong. Its exact aetiology remains unclear,
but genetics and environmental factors are believed to play an important role. High
myopia is an important public health issue, because it can be associated with potentially
blinding complications such as glaucoma, retinal detachment and choroidal neovascularisation.
Increased outdoor activities are strongly associated with reduced progression. Among
all the treatment options, atropine eye drops is the most effective therapy. The
treatment-associated side effects can be reduced by using a lower concentration
of atropine eye drops. Bifocals or progressive lenses also have some small effects.
摘要
近視是香港常見的眼疾,其成因不明,但相信遺傳和環境是重要的因素。 深近視是一項重要的公共衛生議題, 因為它與青光眼、視網膜脫落、脈絡膜新生血管等潛在致盲併發症有關。增加戶外活動與延緩近視加深有密切關係。
在所有治療方案中,阿托品滴眼液的效果最為顯著。與其治療相關的副作用,可以降低滴眼液濃度來減少。 雙焦眼鏡或漸進式眼鏡也對延緩近視加深稍有作用。
Introduction
Myopia (near- or short-sightedness) is one of the commonest human eye diseases and
often has its onset during childhood. It is defined as a refractive state where
light rays entering the eye focus in front of, rather than, on the retina. In East
Asia, myopia has become a major health issue due to its increasingly high prevalence
rates.1 In Hong Kong, the prevalence of myopia in preschool children
is on the rise, increasing significantly from 2.3% to 6.3% over a ten-year period.2
Family physicians are often approahed by anxious parents for advice regarding their
children's myopia. There is a confusing array of management options available in
the market and on the internet. The purpose of this article is to review evidence
on available interventions and strategies, facilitating family physicians to provide
the appropriate advice to patients and their families.
Definitions & biologic basis
Myopia can be divided anatomically into axial and refractive, or clinically into
simple (or school) and pathological (or degenerative).
In anatomical terms, axial myopia is a result of an elongated eyeball. Refractive
myopia is further subdivided into (i) index myopia where there is/are variation(s)
in the refractive index (-ices) of one or more ocular media, and (ii) curvature
myopia where there is/are exaggerated curvature(s) of one or more surface(s) of
the eye, especially the cornea.
Clinically, simple myopia normally refers to those with myopia ranging from 0 to
6 dioptres (D). Locally, in Hong Kong, 1D is conventionally referred as 100 ‘degrees'
in the optical shops while pathological myopia refers to those with myopia of greater
than 8D.
At birth, most babies are slightly hyperopic. In the first two years of life, this
hyperopia gradually decreases in an active process called emmetropization of the
eye. After that, the cornea stabilises but myopia can continue to progress as the
eyeball lengthens over the next two decades.3,4 Myopia generally develops
in early and middle childhood but can well progress into the late teenage years
or even young adulthood.5 A recent study in Chinese eyes have demonstrated
that children's refractive error at the age of 11 years were already similar to
their parents and the estimated myopia in these children by the age of 18 would
be up to 2.0D more severe than their parents.6
Pathogenesis
Despite a long history of scientific research and significant interest in the causes
of myopia in the past three or more decades, the exact aetiology remains to be elucidated.
There are, however, many postulated theories, with genetics and environmental factors
being the two most studied.
The genetic theory for myopia is based on familial clustering. Sibling risk ratios
are high in myopia and even higher for pathological myopia.7 However,
sibling similarities may also be contributed by exposure to the same myopigenic
environmental factors.8 It is also consistently found that children with
myopic parents have a higher prevalence of myopia but the relative risk varies substantially.
In areas where the prevalence of myopia is high, such as East Asia, the relative
risk is found to be lower.9 Several recent reviews suggested a list of
genes to be associated with myopia. In syndromic high myopia, the participation
of genes involved in scleral extracellular matrix is a common feature. However,
for non-syndromic high myopia, a large number of chromosomal localizations have
been reported but few specific genes have been identified. At present, the number
of genes associated with variation in refractive error among school myopia account
for only a small proportion of the variations.10 Thus, school myopia
is faced with a mismatch between the high heritability defined in twin studies and
defined associated allelic variations, a common problem in complex disease genetics
known as missing heritability.11 All these findings imply genetics to
be only one of the many contributions to myopia development.
The importance of environmental risk factors for myopia development stems from animal
experiments. Human observational studies have also consistently demonstrated an
association between myopia and education level, number of years of schooling and
school results.12 In addition, the role of accommodation to myopia development has
been a long-debated and controversial issue over the past century. Some studies
demonstrated an association between the duration of near work and myopia while others
showed weak evidence to support a significant effect of near work to induce myopia.5,11
These conflicting results led to the postulation that sub-optimal accommodation
during near work, known as accommodative lag, creates hyperopic defocus on the retina,
which in turn stimulates axial elongation of the eyeball. However, the literature
has yet to prove whether myopia is a cause or result of accommodative lag.
Complications of myopia
Myopia is associated with pre-senile cataract and glaucoma, though the pathology
of these associations remains unclear. In addition, pathological myopia is associated
with characteristic degenerative changes of the sclera, retinal pigment epithelium
and choroid, and is a major cause of visual impairment. The degenerative changes
are principally thought to be related to mechanical stretching of the involved tissue
as the eyeball lengthens. Table 1 shows a list of the possible
complications associated with high myopia.
In the urban centres of East Asian countries, the overall prevalence of myopia and
pathological myopia in children of school-leaving age are now several times higher
than those in the older cohorts.12-14 The increased prevalence of pathological
myopia will become a major public health and economic burden, as a result of the
resulting rise in related complications.
Interventions
A) Outdoor activities
Many studies have reported a protective effect of increased time spent on any outdoor
activity against myopia development.15-17 Lower myopia was consistently found in
children who have increased time spent outdoors. The true biological explanation
for this protection remains to be elucidated. Some postulated mechanisms include
light intensity, dopamine release and vitamin D.15 These hypotheses require further
systematic testing in future studies.
B) Pharmacological
Atropine eye drops
Atropine is a non-selective muscarinic receptor antagonist and is now the most commonly
used drug in slowing myopia progression. The postulated mechanism includes inhibition
of accommodation, biochemical remodelling of sclera, and increase ultraviolet exposure
secondary to pupil dilatation.18
The Atropine in the Treatment of Myopia Study (ATOM) was a randomised, double-masked,
placebo-controlled trial involving 400 Singapore children.19 This study
showed that the instillation of 1% atropine eye drops nightly in 1 eye over a 2-year
period significantly reduced myopia progression by 77% (0.28D vs. 1.2D in control
vs. atropine groups). Axial length elongation was also significantly reduced with
this regimen (0.38+0.38 mm vs. -0.02+0.35 mm in control vs. atropine groups). However,
discontinuation of treatment was shown to cause a partial rebound effect. This regimen
was also shown to reduce myopia progression significantly by 35% over a 3-year period
(2 year atropine treatment followed by one year no treatment).20
The main side effects of atropine include photophobia due to mydriasis and decreased
near vision due to cycloplegia. As a result, patients on treatment were required
to wear photochromatic, progressive additional lenses. No systemic side effect related
to atropine was reported but postulated side effects include dry eye, dry mouth,
dry throat, flushed skin, constipation and difficulty with micturition. Other ocular
side effects such as allergic conjunctivitis and eyelid contact dermatitis are relatively
uncommon. There was no significant retinal dysfunction 3 months after cessation
of the eye drops.
The ocular side effects mentioned above prohibited wide adoption of atropine use
internationally. However, recent trials with lower doses of atropine (e.g. 0.5%,
0.1%, 0.01%) were associated with fewer side effects and demonstrate significant
reduction of myopia progression.18 This led to a resurgence of its interest
in Hong Kong.
In view of the current evidence, atropine eye drops remain the most popular treatment
option chosen by general ophthalmologists and paediatric ophthalmologists in both
the public and private sector to retard myopia progression. Before starting treatment,
the parents need to be well-informed of evidence of the therapy and the associated
side effects. A good doctor-parent rapport and parental commitment are the key factors
for treatment compliance. Currently, the predominant commercially available topical
atropine in Hong Kong has a concentration of 1%. Patients are instructed to instil
the eye drop once nightly to both eyes and are monitored every 4-monthly. Combined
photochromatic and progressive glasses are prescribed daily for these patients to
prevent ultraviolet-light damage to retina and to improve near vision.
Pirenzepine 2% Eye Gel
Pirenzepine 2% gel is a selective M1 / M4 antagonist which produces less mydriasisand
cycloplegia than atropine. Twice daily application can reduce myopia progression
by 50% over 12 months.21 A common side effect is allergic conjunctivitis,
which can occur in up to 50% of patients. Other ocular side effects and systemic
side effects are uncommon. However, pirenzepine 2% eye gel is not yet commercially
available for use. Thus this treatment is not available in Hong Kong.
C) Optical
Under-correction with spectacles
Based on animal studies, emmetropization was shown to be an active process, mediated
by optical defocus. These studies suggested that placement of a positive lens in
front of the eye causes myopic defocus, which in turn slows axial elongation and
thickens the choroid. Conversely, placement of a negative lens in front of the eye
causes hyperopic defocus and accelerates axial elongation and thins out the choroid.22
It was thus speculated that full-correction of myopia in children could promote
axial elongation, thus myopia progression. However, studies comparing myopia progression
in fullyand under-corrected myopic children with spectacles or single vision lenses
(SVL) have produced conflicting results. And so this therapy is not a common practice
by ophthalmologists in Hong Kong.
Bifocals or progressive addition lenses
Bifocal or progressive addition lenses have two or more distinct optical powers.
They are commonly used in people with presbyopia such that their vision is not jeopardised
with reduced accommodation. The rationale for using bifocal or progressive addition
lenses to correct myopia in children was based on the benefit of reducing defective
accommodative effort, which was speculated to improve retinal image quality in those
with high accommodative lag. This was thought to prevent potential aberrant eye
growth.
In a 30-month randomised controlled trial (RCT) involving 82 children with near
point esophoria, the use of bifocals to correct myopia was found to have a small
but significant benefit in retarding myopia progression.26 RCTs on the
use of progressive addition lenses to correct myopia suggested either no effect
on myopia retardation or a minor but significant effect in the first year only.27,28
Based on these findings, it is concluded that the use of bifocals or progressive
lenses to correct myopic children has little effect (-0.50D at most) on myopia retardation
and this effect is probably too modest to warrant a change from the use of single
vision lenses to bifocals or progressive lenses. This therapy is a common practice
by optometrists in Hong Kong.
D) Use of various types of contact lenses
The rationale for using contact lenses (CL) to correct myopia stems from the beliefs
that they can flatten the cornea, retard axial elongation and reinforce the sclera,
which was postulated to in turn retard myopia progression.
A RCT of 175 children showed that the use of soft CL did not have any significant
effect in retarding myopia progression when compared with spectacle use.29
The use of rigid gas permeable (RGP) CL in a small, non-randomised trial demonstrated
reduction in myopia progression when compared with spectacle wear but the effects
were accounted for by corneal flattening only.30 Conversely, a large
RCT involving 428 children failed to show any significant benefit with the use of
RGP CL when compared with spectacles in myopia retardation.31
Orthokeratology lenses (OKL) is a type of RGP CL that temporarily reshapes the cornea.
It differs from other CLs in that it is commonly worn at bedtime and removed upon
awakening. It is particularly appealing to parents who want their children to be
spectacle-free during the day. In addition, its use was postulated to have an effect
on myopia retardation from peripheral myopia defocus, which acts as a signal to
dampen eye growth and axial elongation. Many studies on OKL were carried out but
few if any to date have definitively demonstrated the reduction in myopia progression
to be permanent.32,33 The hypothesised permanent benefits with the use
of OKL in myopia retardation have yet to be proven scientifically. Unfortunately,
complications, some of which are serious and blinding (such as recurrent corneal
erosion, infective keratitis, induced corneal astigmatism, corneal pigmentation)
are associated with its use.34-36 This is a common practice by optometrists
and some private ophthalmologists in Hong Kong. This therapy is not available in
the public sector. However, the authors cautioned that the risks associated with
OKL must be carefully weighed against the possible benefits. Parents should be counselled
adequately and made aware of these potentially blinding complications that may arise
from its use. Immediate medical advice should be sought when there is any symptom
of keratitis, such as pain, redness, and blurring of vision.
Conclusions
Myopia in children is a rising threat in Hong Kong. High or pathological myopia
gives rise to potentially blinding complications that will be a burden to the health
care system as well as the economy. To date, the only interventions that had been
shown to be of scientific benefit are increasing outdoor activities and the use
of topical atropine and pirenzepine. Myopia correction using bifocal or progressive
addition lenses were also found to reduce myopia progression; unfortunately, effects
were only temporary and at most modest. Other strategies including the use of CL
revealed equivocal or only temporary effects in myopia retardation. In order to
stem the tide of this potential myopic ‘epidemic', perhaps we too may ask our Hong
Kong families and schools to consider the Singaporean Health Promotion Board motto:
‘‘Keep Myopia at Bay, Go Outdoors and Play!'
Madeline KM Kwok, MBChB, MRCS(Ed), FCOphthHK, FHKAM(Ophth)
Resident
Hong Kong Eye Hospital
Jason CS Yam, MBBS, MPH, FRCS(Ed), FHKAM(Ophth)
Assistant Professor
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong
Kong, Prince of Wales Hospital & Alice Ho Miu Ling Nethersole Hospital
See-mei Lee,, MB BCh BAO, DPD, DFM
Private Practitioner
Dr George Medical Clinics
Alvin L Young, FRCS (Irel), FCOphthHK, FRCOphth, FHKAM (Ophth)
Chief of Service and Cluster Coordinator
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong
Kong, Prince of Wales Hospital & Alice Ho Miu Ling Nethersole Hospital
Correspondence to : Dr Alvin L Young, Chief of Service and Cluster Coordinator,
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong
Kong, Prince of Wales Hospital, Shatin, Hong Kong. SAR
Email: youngla@ha.org.hk
References
- Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia.
Ophthalmic Physiol Opt 2012;32(1):3-16.
- Fan DS, Lai C, Lau HH, et al. Change in vision disorders among Hong Kong preschoolers
in 10 years. Clin Experiment Ophthalmol 2011;39(5):398-403.
- Gordon RA, Donzis PB. Refractive development of the human eye. Arch Ophthalmol 1985;103(6):785-789.
- Fan DS, Lam DS, Lam RF, et al. Prevalence, incidence, and progression of myopia
of school children in Hong Kong. Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1071-1075.
- Cumberland PM, Peckham CS, Rahi JS. Inferring myopia over the lifecourse from uncorrected
distance visual acuity in childhood. Br J Ophthalmol 2007;91(2):151-153.
- Liang YB, Lin Z, Vasudevan B, et al. Generational difference of refractive error
in the baseline study of the Beijing Myopia Progression Study. Br J Ophthalmol.
2013 Apr 16. [Epub ahead of print]
- Guggenheim JA, Kirov G, Hodson SA. The heritability of high myopia: a reanalysis
of Goldschmidt's data. J Med Genet 2000;37(3):227-231.
- Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet 2012;379(9827): 1739-1748.
- Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex
diseases. Nature 2009;461(7265):747-753.
- Morgan I, Rose K. How genetic is school myopia? Prog Retin Eye Res 2005;24(1):1-38.
- Mutti DO, Zadnik K. Has near work's star fallen? Optom Vis Sci 2009;86(2):76-78.
- Li n LL, Sh i h YF, Hs i a o CK, et al . Prevalence of myopiain Taiwanese schoolchildren:
1983 to 2000. Ann Acad Med Singapore 2004;33(1):27-33.
- Wu HM, Seet B, Yap EP, et al. Does education explain ethnic differences in myopia
prevalence? A population-based study of young adult males in Singapore. Optom Vis
Sci 2001;78(4):234-239.
- He M, Zeng J, Liu Y, et al. Refractive error and visual impairment in urban children
in southern china. Invest Ophthalmol Vis Sci 2004;45(3):793-799.
- Rose KA, Morgan IG, Ip J, et al. Outdoor activity reduces the prevalence of myopia
in children. Ophthalmology 2008;115(8):1279-1285.
- Mutti DO, Mitchell GL, Moeschberger ML, et al. Parental myopia, near work, school
achievement, and children's refractive error. Invest Ophthalmol Vis Sci 2002;43(12):3633-3640.
- Jones LA, Sinnott LT, Mutti DO, et al. Parental history of myopia, sports and outdoor
activities, and future myopia. Invest Ophthalmol Vis Sci 2007;48(8):3524-3532.
- Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia:
safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of
Myopia 2). Ophthalmology 2012;119(2):347-354.
- Chua WH, Balakrishnan V, Chan YH, et al. Atropine for the treatment of childhood
myopia. Ophthalmology 2006;113(12):2285-2291.
- Tong L, Huang XL, Koh AL, et al. Atropine for the treatment of childhood myopia:
effect on myopia progression after cessation of atropine. Ophthalmology 2009;116(3):572-579.
- Tan DT, Lam DS, Chua WH, et al. One-year multicenter, doublemasked, placebo-controlled,
parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children
with myopia. Ophthalmology 2005;112(1):84-91.
- Zhu X, Wallman J. Temporal properties of compensation for positive and negative
spectacle lenses in chicks. Invest Ophthalmol Vis Sci 2009;50(1):37-46.
- Tokoro T, Kabe S. Treatment of the myopia and the changes in optical components.
Report II. Full-or under-correction of myopia by glasses. Nihon Ganka Gakkai Zasshi
1965;69(2):140-144.
- Chung K, Mohidin N, O'Leary DJ. Undercorrection of myopia enhances rather than inhibits
myopia progression. Vision Res 2002;42(22):2555-2559.
- Ong E, Grice K, Held R, et al. Effects of spectacle intervention on the progression
of myopia in children. Optom Vis Sci 1999;76(6):363-369.
- Fulk GW, Cyert LA, Parker DE. A randomized trial of the effect of single-vision
vs. bifocal lenses on myopia progression in children with esophoria. Optom Vis Sci
2000;77(8):395-401.
- Edwards MH, Li RW, Lam CS, et al. The Hong Kong progressive lens myopia control
study: study design and main findings. Invest Ophthalmol Vis Sci 2002;43(9):2852-2858.
- Gwiazda J, Hyman L, Hussein M, et al. A randomized clinical trial of progressive
addition lenses versus single vision lenses on the progression of myopia in children.
Invest Ophthalmol Vis Sci 2003;44(4):1492-1500.
- Horner DG, Soni PS, Salmon TO, et al. Myopia progression in adolescent wearers of
soft contact lenses and spectacles. Optom Vis Sci 1999;76(7):474-479.
- Grosvenor T, Perrigin D, Perrigin J, et al. Rigid gas-permeable contact lenses for
myopia control: effects of discontinuation of lens wear. Optom Vis Sci 1991;68(5):385-389.
- Katz J, Schein OD, Levy B, et al. A randomized trial of rigid gas permeable contact
lenses to reduce progression of children's myopia. Am J Ophthalmol 2003;136(1):82-90.
- Polse KA, Brand RJ, Keener RJ, et al. The Berkeley Orthokeratology Study, part III:
safety. Am J Optom Physiol Opt 1983;60(4):321-328.
- Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year
randomized clinical trial. Invest Ophthalmol Vis Sci 2012;53(11):7077-7085.
- Van Meter WS, Musch DC, Jacobs DS, et al. Safety of overnight orthokeratology for
myopia: a report by the American Academy of Ophthalmology. Ophthalmology 2008;115(12):2301-2313.
- Young AL, Leung AT, Cheng LL, et al. Orthokeratology lensrelated corneal ulcers
in children: a case series. Ophthalmology. 2004 Mar;111(3):590-595.
- Wong VW, Lai TY, Chi SC, et al. Pediatric ocular surface infections: a 5-year review
of demographics, clinical features, risk factors, microbiological results, and treatment.
Cornea. 2011 Sep;30(9):995-1002.
|